(DNLI)
Denali Therapeutics Inc (DNLI) with a beta value of 1.02 appears to be a promising investment opportunity.
Sana Meer
On Tuesday, Denali Therapeutics Inc (NASDAQ: DNLI) opened higher 7.43% from the last session, before settling in for the closing ...
Denali Therapeutics Inc (DNLI) is expecting 24.70% growth in the next quarter: What can investors do to maximize their returns?
Steve Mayer
Denali Therapeutics Inc (NASDAQ: DNLI) kicked off on Tuesday, down -3.78% from the previous trading day, before settling in for ...
Denali Therapeutics Inc (DNLI) ticks all the boxes for top investors with its surprise performance of 2.63% last month.
Shaun Noe
Denali Therapeutics Inc (NASDAQ: DNLI) on Friday, soared 3.51% from the previous trading day, before settling in for the closing ...
Denali Therapeutics Inc (DNLI) went down -10.63% yesterday: Is this the Most Sought-After Stock Today?
Shaun Noe
Denali Therapeutics Inc (NASDAQ: DNLI) open the trading on Wednesday, with a bit cautious approach as it glided -10.63% to ...
